Stress Urinary Incontinence Clinical Trials

Find Stress Urinary Incontinence Clinical Trials Near You

Prospective and Comparative Evaluation of a Medical Device Composed of a Perineal Probe Connected to a Mobile Application in the Management of Stress Urinary Incontinence.

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Stress urinary incontinence (SUI) affects around 40% of women and has a major impact on quality of life. The gold standard for the treatment of SUI is pelvicfloor rehabilitation, but this presents constraints in terms of availability of healthcare professionals, as well as organization and travel for patients. Innovative devices offer self-training exercises for the pelvicfloor, thus promoting motivation and adherence to treatment. The hypothesis of this study is to prove that the use of a pelvicfloor medical device combined with 2 rehabilitation sessions is not inferior to pelvic-perineal rehabilitation.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• Patients with moderate, severe or very severe stress urinary incontinence or mixed stress urinary incontinence (according to ICIQ-UI SF questionnaire score: moderate (6-12), severe (13-18) and very severe (19-21))

• Patient aged between 18 and 60

• Patient with a quality of life score measured with the I-QoL questionnaire less than or equal to 70 (score measured from 0 to 100, with poor quality of life: 0-35; average quality of life: 36-70; good quality of life: 71-100)

• Not to have given birth in the last 6 months (to avoid post-partum physiological recovery)

• Signed informed consent

• Effective contraception throughout the study (declarative)

• Patient must have a smartphone running at least Android 7 and iOS 12

• Patient must be able to read and write French

Locations
Other Locations
France
CHU de Nantes
RECRUITING
Nantes
Contact Information
Primary
Thibault THUBERT, PHD
thibault.thubert@chu-nantes.fr
02.53.48.24.43
Backup
Selma EL ANDALOUSSI, manager
selma.elandaloussi@chu-nantes.fr
02.53.48.28.52
Time Frame
Start Date: 2024-11-25
Estimated Completion Date: 2026-11-25
Participants
Target number of participants: 138
Treatments
Experimental: EMY (connected biofeedback medical device)
2 rehabilitation between M0 and M2 and pelvic-perineal exercises with the EMY device on 3 different days a week, for 15 minutes, over a period of 3 months.
No_intervention: standard
15 sessions of pelvic floor rehabilitation (gold standard)
Sponsors
Leads: Nantes University Hospital
Collaborators: FIZIMED Company

This content was sourced from clinicaltrials.gov